Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host
dc.contributor.author | Hemmi, Silvio | |
dc.contributor.author | Spindler, Katherine R. | |
dc.date.accessioned | 2020-01-13T15:17:14Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2020-01-13T15:17:14Z | |
dc.date.issued | 2019-12 | |
dc.identifier.citation | Hemmi, Silvio; Spindler, Katherine R. (2019). "Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host." FEBS Letters 593(24): 3649-3659. | |
dc.identifier.issn | 0014-5793 | |
dc.identifier.issn | 1873-3468 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/153088 | |
dc.publisher | Academic Press | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | mouse adenovirus | |
dc.subject.other | viral pathogenesis | |
dc.subject.other | PKR | |
dc.subject.other | adenovirus vaccines | |
dc.subject.other | adenovirus vectors | |
dc.subject.other | alpha‐defensins | |
dc.subject.other | host susceptibility to viruses | |
dc.subject.other | immunoproteasome | |
dc.subject.other | Ly6 | |
dc.title | Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Biological Chemistry | |
dc.subject.hlbtoplevel | Science | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/153088/1/feb213699.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/153088/2/feb213699_am.pdf | |
dc.identifier.doi | 10.1002/1873-3468.13699 | |
dc.identifier.source | FEBS Letters | |
dc.identifier.citedreference | Meurs E, Chong K, Galabru J, Thomas NB, Kerr IM, Williams BRG and Hovanessian AG ( 1990 ) Molecular cloning and characterization of the human double‐stranded RNA‐activated protein kinase induced by interferon. Cell 62, 379 – 390. | |
dc.identifier.citedreference | Mathews MB and Shenk T ( 1991 ) Adenovirus virus‐associated RNA and translational control. J Virol 65, 5657 – 5662. | |
dc.identifier.citedreference | Goodman DE, Pretto CD, Krepostman TA, Carnahan KE and Spindler KR ( 2019 ) Enhanced replication of mouse adenovirus type 1 following virus‐induced degradation of protein kinase R (PKR). MBio 10, e00668 – 19. | |
dc.identifier.citedreference | Ginder DR ( 1964 ) Increased susceptibility of mice infected with mouse adenovirus to Escherichia coli ‐induced pyelonephritis. J Exp Med 120, 1117 – 1128. | |
dc.identifier.citedreference | Garnett CT, Erdman D, Xu W and Gooding LR ( 2002 ) Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76, 10608 – 10616. | |
dc.identifier.citedreference | Garnett CT, Talekar G, Mahr JA, Huang W, Zhang Y, Ornelles DA and Gooding LR ( 2009 ) Latent species C adenoviruses in human tonsil tissues. J Virol 83, 2417 – 2428. | |
dc.identifier.citedreference | Horvath J, Palkonyay L and Weber J ( 1986 ) Group C adenovirus DNA sequences in human lymphoid cells. J Virol 59, 189 – 192. | |
dc.identifier.citedreference | Kosulin K, Geiger E, Vécsei A, Huber W‐d, Rauch M, Brenner E, Wrba F, Hammer K, Innerhofer A, Pötschger U et al. ( 2016 ) Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect 22, 381 e1 – 381 e8. | |
dc.identifier.citedreference | Welton AR, Chesler EJ, Sturkie C, Jackson AU, Hirsch GN and Spindler KR ( 2005 ) Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1. J Virol 79, 11517 – 11522. | |
dc.identifier.citedreference | Spindler KR, Welton AR, Lim ES, Duvvuru S, Althaus IW, Imperiale JE, Daoud AI and Chesler EJ ( 2010 ) The major locus for mouse adenovirus susceptibility maps to genes of the hematopoietic cell surface‐expressed LY6 family. J Immunol 184, 3055 – 3062. | |
dc.identifier.citedreference | Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P and Rice CM ( 2011 ) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481 – 485. | |
dc.identifier.citedreference | Mar KB, Rinkenberger NR, Boys IN, Eitson JL, McDougal MB, Richardson RB and Schoggins JW ( 2018 ) LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nat Commun 9, 3603. | |
dc.identifier.citedreference | Hemmi S, Vidovszky MZ, Ruminska J, Ramelli S, Decurtins W, Greber UF and Harrach B ( 2011 ) Genomic and phylogenetic analyses of murine adenovirus 2. Virus Res 160, 128 – 135. | |
dc.identifier.citedreference | Smith AL, Winograd DF and Burrage TG ( 1986 ) Comparative biological characterization of mouse adenovirus strains FL and K87 and seroprevalence in laboratory rodents. Arch Virol 91, 233 – 246. | |
dc.identifier.citedreference | Ramke M, Lee JY, Dyer DW, Seto D, Rajaiya J and Chodosh J ( 2017 ) The 5’UTR in human adenoviruses: Leader diversity in late gene expression. Sci Rep 7, 618. | |
dc.identifier.citedreference | Sheppard M, Werner W, McCoy RJ and Johnson MA ( 1998 ) The major late promoter and bipartite leader sequence of fowl adenovirus. Arch Virol 143, 537 – 548. | |
dc.identifier.citedreference | Singh AK, Nguyen TH, Vidovszky MZ, Harrach B, Benkő M, Kirwan A, Joshi L, Kilcoyne M, Berbis MÁ, Cañada FJ et al. ( 2018 ) Structure and N‐acetylglucosamine binding of the distal domain of mouse adenovirus 2 fibre. J Gen Virol 99, 1494 – 1508. | |
dc.identifier.citedreference | Wilson SS, Bromme BA, Holly MK, Wiens ME, Gounder AP, Sul Y and Smith JG ( 2017 ) Alpha‐defensin‐dependent enhancement of enteric viral infection. PLoS Pathog 13, e1006446. | |
dc.identifier.citedreference | Robinson M, Li B, Ge Y, Ko D, Yendluri S, Harding T, VanRoey M, Spindler KR and Jooss K ( 2009 ) Novel immunocompetent murine tumor model for evaluation of conditionally replication‐competent (oncolytic) murine adenoviral vectors. J Virol 83, 3450 – 3562. | |
dc.identifier.citedreference | Young AM, Archibald KM, Tookman LA, Pool A, Dudek K, Jones C, Williams SL, Pirlo KJ, Willis AE, Lockley M et al. ( 2012 ) Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4–100K expression in vitro and in vivo. Mol Ther 20, 1676 – 88. | |
dc.identifier.citedreference | Lei J, Jacobus EJ, Taverner WK, Fisher KD, Hemmi S, West K, Slater L, Lilley F, Brown A, Champion B et al. ( 2018 ) Expression of human CD46 and trans‐complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. J Immunother Cancer 6, 55. | |
dc.identifier.citedreference | Top FH Jr ( 1975 ) Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J Biol Med 48, 185 – 195. | |
dc.identifier.citedreference | Goffin E, Javaux J, Destexhe E, Pretto CD, Spindler KR, Machiels B and Gillet L ( 2019 ) Oral vaccination with replication‐competent adenovirus in mice reveals dissemination of the viral vaccine beyond the gastrointestinal tract. J Virol 93, e00237-19. | |
dc.identifier.citedreference | Wahl A, De C, Abad Fernandez M, Lenarcic EM, Xu Y, Cockrell AS, Cleary RA, Johnson CE, Schramm NJ, Rank LM et al. ( 2019 ) Precision mouse models with expanded tropism for human pathogens. Nat Biotechnol 37: 1163 – 1173. | |
dc.identifier.citedreference | Dutta D and Clevers H ( 2017 ) Organoid culture systems to study host‐pathogen interactions. Curr Opin Immunol 48, 15 – 22. | |
dc.identifier.citedreference | Holly MK and Smith JG ( 2018 ) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol 92, e00250‐18. | |
dc.identifier.citedreference | Hartley JW and Rowe WP ( 1960 ) A new mouse virus apparently related to the adenovirus group. Virology 11, 645 – 647. | |
dc.identifier.citedreference | Evans CA, Dowell M and Green RG ( 1950 ) The effects of viruses on intraocular tissues; infections with the virus of fox encephalitis (canine hepatitis). J Infect Dis 86, 1 – 11. | |
dc.identifier.citedreference | Yates VJ and Fry DE ( 1957 ) Observations on a chicken embryo lethal orphan (CELO) virus. Am J Vet Res 18, 657 – 660. | |
dc.identifier.citedreference | Klein M, Earley E and Zellat J ( 1959 ) Isolation from cattle of a virus related to human adenovirus. Proc Soc Exp Biol Med 102, 1 – 4. | |
dc.identifier.citedreference | Kajon AE, Brown CC and Spindler KR ( 1998 ) Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J Virol 72, 1219 – 1223. | |
dc.identifier.citedreference | Guida JD, Fejer G, Pirofski LA, Brosnan CF and Horwitz MS ( 1995 ) Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol 69, 7674 – 7681. | |
dc.identifier.citedreference | Ashley SL, Pretto CD, Stier MT, Kadiyala P, Castro‐Jorge L, Hsu T‐H, Doherty R, Carnahan KE, Castro MG, Lowenstein PR et al. ( 2017 ) Matrix metalloproteinase activity in infections by an encephalitic virus, mouse adenovirus type 1. J Virol 91, e01412 – 16. | |
dc.identifier.citedreference | Kring SC, King CS and Spindler KR ( 1995 ) Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred Swiss mice. J Virol 69, 8084 – 8088. | |
dc.identifier.citedreference | Spindler KR, Fang L, Moore ML, Hirsch GN, Brown CC and Kajon A ( 2001 ) SJL/J mice are highly susceptible to infection by mouse adenovirus type 1. J Virol 75, 12039 – 12046. | |
dc.identifier.citedreference | Blailock ZR, Rabin ER and Melnick JL ( 1967 ) Adenovirus endocarditis in mice. Science 157, 69 – 70. | |
dc.identifier.citedreference | Blailock ZR, Rabin ER and Melnick JL ( 1968 ) Adenovirus myocarditis in mice: an electron microscopic study. Exp Mol Pathol 9, 84 – 96. | |
dc.identifier.citedreference | McCarthy MK, Procario MC, Twisselmann N, Wilkinson JE, Archambeau AJ, Michele DE, Day SM and Weinberg JB ( 2015 ) Proinflammatory effects of interferon gamma in mouse adenovirus 1 myocarditis. J Virol 89, 468 – 479. | |
dc.identifier.citedreference | Weinberg JB, Stempfle GS, Wilkinson JE, Younger JG and Spindler KR ( 2005 ) Acute respiratory infection with mouse adenovirus type 1. Virology 340, 245 – 254. | |
dc.identifier.citedreference | Procario MC, Levine RE, McCarthy MK, Kim E, Zhu L, Chang C‐H, Hershenson MB and Weinberg JB ( 2012 ) Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice. J Virol 86, 4194 – 4203. | |
dc.identifier.citedreference | Hashimoto K, Sugiyama T and Saski S ( 1966 ) An adenovirus isolated from the feces of mice. I. Isolation and identification. Jpn J Microbiol 10, 115 – 125. | |
dc.identifier.citedreference | Takeuchi A and Hashimoto K ( 1976 ) Electron microscope study of experimental enteric adenovirus infection in mice. Infect Immun 13, 569 – 580. | |
dc.identifier.citedreference | Cauthen AN and Spindler KR ( 1996 ) Sequence of the mouse adenovirus type‐1 DNA encoding the 100‐kDa, 33‐kDa and DNA binding proteins. Gene 168, 183 – 187. | |
dc.identifier.citedreference | Hashimoto K, Sugiyama T, Yoshikawa M and Sasaki S ( 1970 ) Intestinal resistance in the experimental enteric infection of mice with a mouse adenovirus. I. Growth of the virus and appearance of a neutralizing substance in the intestinal tract. Jpn J Microbiol 14, 381 – 395. | |
dc.identifier.citedreference | Klempa B, Kruger DH, Auste B, Stanko M, Krawczyk A, Nickel K f, Uberla K and Stang A ( 2009 ) A novel cardiotropic murine adenovirus representing a distinct species of mastadenoviruses. J Virol 83, 5749 – 5759. | |
dc.identifier.citedreference | Becker SD, Bennett M, Stewart JP and Hurst JL ( 2007 ) Serological survey of virus infection among wild house mice ( Mus domesticus ) in the UK. Lab Anim 41, 229 – 238. | |
dc.identifier.citedreference | Singleton GR, Smith AL, Shellam GR, Fitzgerald N and Müller WJ ( 1993 ) Prevalence of viral antibodies and helminths in field populations of house mice ( Mus domesticus ) in southeastern Australia. Epidemiol Infect 110, 399 – 417. | |
dc.identifier.citedreference | Smith AL, Singleton GR, Hansen GM and Shellam G ( 1993 ) A serologic survey for viruses and Mycoplasma pulmonis among wild house mice ( Mus domesticus ) in southeastern Australia. J Wildl Dis 29, 219 – 229. | |
dc.identifier.citedreference | Dammann P, Hilken G, Hueber B, Köhl W, Bappert MT and Mähler M ( 2011 ) Infectious microorganisms in mice ( Mus musculus ) purchased from commercial pet shops in Germany. Lab Anim 45, 271 – 275. | |
dc.identifier.citedreference | Grove KA, Smith PC, Booth CJ and Compton SR ( 2012 ) Age‐associated variability in susceptibility of Swiss Webster mice to MPV and other excluded murine pathogens. J Am Assoc Lab Anim Sci 51, 789 – 796. | |
dc.identifier.citedreference | Henderson KS, Perkins CL, Havens RB, Kelly MJ, Francis BC, Dole VS and Shek WR ( 2013 ) Efficacy of direct detection of pathogens in naturally infected mice by using a high‐density PCR array. J Am Assoc Lab Anim Sci 52, 763 – 772. | |
dc.identifier.citedreference | Marx JO, Gaertner DJ and Smith AL ( 2017 ) Results of survey regarding prevalence of adventitial infections in mice and rats at biomedical research facilities. J Am Assoc Lab Anim Sci 56, 527 – 533. | |
dc.identifier.citedreference | Williams SH, Che X, Garcia JA, Klena JD, Lee B, Muller D, Ulrich W, Corrigan RM, Nichol S, Jain K et al. ( 2018 ) Viral diversity of house mice in New York City. MBio 9, e01354 – 17. | |
dc.identifier.citedreference | Phan TG, Kapusinszky B, Wang C, Rose RK, Lipton HL and Delwart EL ( 2011 ) The fecal viral flora of wild rodents. PLoS Pathog 7, e1002218. | |
dc.identifier.citedreference | Wu Z, Lu L, Du J, Yang L, Ren X, Liu B, Jiang J, Yang J, Dong J, Sun L et al. ( 2018 ) Comparative analysis of rodent and small mammal viromes to better understand the wildlife origin of emerging infectious diseases. Microbiome 6, 178. | |
dc.identifier.citedreference | Zheng XY, Qiu M, Ke X‐M, Guan W‐J, Li J‐M, Huo S‐T, Chen S‐W, Zhong X‐S, Zhou W, Xiong Y‐Q et al. ( 2016 ) Detection of novel adenoviruses in fecal specimens from rodents and shrews in southern China. Virus Genes 52, 417 – 421. | |
dc.identifier.citedreference | Smith AL and Barthold SW ( 1987 ) Factors influencing susceptibility of laboratory rodents to infection with mouse adenovirus strains K87 and FL. Arch Virol 95, 143 – 148. | |
dc.identifier.citedreference | Spindler KR, Moore ML and Cauthen AN ( 2007 ) Mouse adenoviruses. In The Mouse in Biomedical Research ( Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE and Smith AL, eds). pp. 49 – 65. Academic Press: New York, NY. | |
dc.identifier.citedreference | Smith K and Spindler KR ( 1999 ) Murine adenovirus. In Persistent Viral Infections ( Ahmed R and Chen I, eds), pp. 477 – 484. John Wiley & Sons, New York, NY. | |
dc.identifier.citedreference | Smith K, Brown CC and Spindler KR ( 1998 ) The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice. J Virol 72, 5699 – 5706. | |
dc.identifier.citedreference | Ball AO, Beard CW, Villegas P and Spindler KR ( 1991 ) Early region 4 sequence and biological comparison of two isolates of mouse adenovirus type 1. Virology 180, 257 – 265. | |
dc.identifier.citedreference | Ball AO, Williams ME and Spindler KR ( 1988 ) Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function. J Virol 62, 3947 – 3957. | |
dc.identifier.citedreference | Temple M, Antoine G, Stahl S, Winnacker Ernst‐L and Delius H ( 1981 ) Replication of mouse adenovirus strain FL DNA. Virology 109, 1 – 12. | |
dc.identifier.citedreference | Meissner JD, Hirsch GN, LaRue EA, Fulcher RA and Spindler KR ( 1997 ) Completion of the DNA sequence of mouse adenovirus type 1: sequence of E2B, L1, and L2 (18–51 map units). Virus Res 51, 53 – 64. | |
dc.identifier.citedreference | Davison AJ, Benko M and Harrach B ( 2003 ) Genetic content and evolution of adenoviruses. J Gen Virol 84, 2895 – 2908. | |
dc.identifier.citedreference | Kitajewski J, Schneider RJ, Safer B, Munemitsu SM, Samuel CE, Thimmappaya B and Shenk T ( 1986 ) Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon‐induced eIF‐2 alpha kinase. Cell 45, 195 – 200. | |
dc.identifier.citedreference | Ball AO, Beard CW, Redick SD and Spindler KR ( 1989 ) Genome organization of mouse adenovirus type 1 early region 1: a novel transcription map. Virology 170, 523 – 536. | |
dc.identifier.citedreference | Smith K, Ying B, Ball AO, Beard CW and Spindler KR ( 1996 ) Interaction of mouse adenovirus type 1 early region 1A protein with cellular proteins pRb and p107. Virology 224, 184 – 197. | |
dc.identifier.citedreference | Fang L, Stevens JL, Berk AJ and Spindler KR ( 2004 ) Requirement of Sur2 for efficient replication of mouse adenovirus type 1. J Virol 78, 12888 – 12900. | |
dc.identifier.citedreference | Beard CW, Ball AO, Wooley EH and Spindler KR ( 1990 ) Transcription mapping of mouse adenovirus type 1 early region 3. Virology 175, 81 – 90. | |
dc.identifier.citedreference | Beard CW and Spindler KR ( 1996 ) Analysis of early region 3 mutants of mouse adenovirus type 1. J Virol 70, 5867 – 5874. | |
dc.identifier.citedreference | Cauthen AN, Brown CC and Spindler KR ( 1999 ) In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 mutant. J Virol 73, 8640 – 8646. | |
dc.identifier.citedreference | Burgert H‐G and Kvist S ( 1985 ) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41, 987 – 997. | |
dc.identifier.citedreference | Kring SC and Spindler KR ( 1996 ) Lack of effect of mouse adenovirus type 1 infection on the cell surface expression of major histocompatibility complex class I antigens. J Virol 70, 5495 – 5502. | |
dc.identifier.citedreference | Kring SC, Ball AO and Spindler KR ( 1992 ) Transcription mapping of mouse adenovirus type 1 early region 4. Virology 190, 248 – 255. | |
dc.identifier.citedreference | Gilson T, Blanchette P, Ballmann MZ, Papp T, Pénzes JJ, Benkő M, Harrach B and Branton PE ( 2016 ) Using the E4orf6‐based E3 ubiquitin ligase as a tool to analyze the evolution of adenoviruses. J Virol 90, 7350 – 7367. | |
dc.identifier.citedreference | Song B, Hu S‐l, Darai G, Spindler KR and Young CS ( 1996 ) Conservation of DNA sequence in the predicted major late promoter regions of selected mastadenoviruses. Virology 220, 390 – 401. | |
dc.identifier.citedreference | Lenaerts L, Daelemans D, Geukens N, De Clercq E and Naesens L ( 2006 ) Mouse adenovirus type 1 attachment is not mediated by the coxsackie‐adenovirus receptor. FEBS Lett 580, 3937 – 3942. | |
dc.identifier.citedreference | Raman SR, Hsu TH, Ashley SL and Spindler KR ( 2009 ) Integrin and heparan sulfate usage as receptors for mouse adenovirus type 1. J Virol 83, 2831 – 2838. | |
dc.identifier.citedreference | Lenaerts L, McVey JH, Baker AH, Denby L, Nicklin S, Verbeken E and Naesens L ( 2009 ) Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting. J Gene Med 11, 119 – 127. | |
dc.identifier.citedreference | Ashley SL, Welton AR, Harwood KM, Rooijen NV and Spindler KR ( 2009 ) Mouse adenovirus type 1 infection of macrophages. Virology 390, 307 – 314. | |
dc.identifier.citedreference | Charles PC, Guida JD, Brosnan CF and Horwitz MS ( 1998 ) Mouse adenovirus type‐1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 245, 216 – 228. | |
dc.identifier.citedreference | Gralinski LE, Ashley SL, Dixon SD and Spindler KR ( 2009 ) Mouse adenovirus type 1‐induced breakdown of the blood‐brain barrier. J Virol 83, 9398 – 9410. | |
dc.identifier.citedreference | Hsu T‐H, Althaus IW, Foreman O and Spindler KR ( 2012 ) Contribution of a single host genetic locus to mouse adenovirus type 1 infection and encephalitis. MBio 3, e00131 – 12. | |
dc.identifier.citedreference | Tirumuru N, Pretto CD, Castro Jorge LA and Spindler KR ( 2016 ) Mouse adenovirus type 1 early region 1A effects on the blood‐brain barrier. mSphere 1, e00079‐16. | |
dc.identifier.citedreference | Chandrasekaran A, Adkins LJ, Seltzer HM, Pant K, Tryban ST, Molloy CT and Weinberg JB ( 2019 ) Age‐dependent effects of immunoproteasome deficiency on mouse adenovirus type 1 pathogenesis. J Virol 93, e00569‐19. | |
dc.identifier.citedreference | Molloy CT, Adkins LJ, Griffin C, Singer K and Weinberg JB ( 2018 ) Mouse adenovirus type 1 infection of adipose tissue. Virus Res 244, 90 – 98. | |
dc.identifier.citedreference | Gounder AP, Myers ND, Treuting PM, Bromme BA, Wilson SS, Wiens ME, Lu W, Ouellette AJ, Spindler KR, Parks WC et al. ( 2016 ) Defensins potentiate a neutralizing antibody response to enteric viral infection. PLoS Pathog 12, e1005474. | |
dc.identifier.citedreference | Moore ML, McKissic EL, Brown CC, Wilkinson JE and Spindler KR ( 2004 ) Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton’s tyrosine kinase. J Virol 78, 5584 – 5590. | |
dc.identifier.citedreference | Inada T and Uetake H ( 1978 ) Cell‐mediated immunity assayed by 51 Cr release test in mice infected with mouse adenovirus. Infect Immun 20, 1 – 5. | |
dc.identifier.citedreference | Inada T and Uetake H ( 1978 ) Nature and specificity of effector cells in cell‐mediated cytolysis of mouse adenovirus‐infected cells. Infect Immun 22, 119 – 124. | |
dc.identifier.citedreference | Inada T and Uetake H ( 1978 ) Cell‐mediated immunity to mouse adenovirus infection: macrophage migration inhibition test. Microbiol Immunol 22, 391 – 401. | |
dc.identifier.citedreference | Inada T and Uetake H ( 1980 ) Cell‐mediated immunity to mouse adenovirus infection: Blocking of macrophage migration inhibition and T cell‐mediated cytolysis of infected cells by anti‐S antigen or anti‐alloantigen serum. Microbiol Immunol 24, 525 – 535. | |
dc.identifier.citedreference | Moore ML, Brown CC and Spindler KR ( 2003 ) T cells cause acute immunopathology and are required for long‐term survival in mouse adenovirus type 1‐induced encephalomyelitis. J Virol 77, 10060 – 10070. | |
dc.identifier.citedreference | Molloy CT, Andonian JS, Seltzer HM, Procario MC, Watson ME and Weinberg JB ( 2017 ) Contributions of CD8 T cells to the pathogenesis of mouse adenovirus type 1 respiratory infection. Virology 507, 64 – 74. | |
dc.identifier.citedreference | Adkins LJ, Molloy CT and Weinberg JB ( 2018 ) Fas activity mediates airway inflammation during mouse adenovirus type 1 respiratory infection. Virology 521, 129 – 137. | |
dc.identifier.citedreference | van der Veen J and Mes A ( 1973 ) Experimental infection with mouse adenovirus in adult mice. Arch Gesamte Virusforsch 42, 235 – 241. | |
dc.identifier.citedreference | Coutelier J‐P, Coulie PG, Wauters P, Heremans H and van der Logt JT ( 1990 ) In vivo polyclonal B‐lymphocyte activation elicited by murine viruses. J Virol 64, 5383 – 5388. | |
dc.identifier.citedreference | Coutelier J‐P, van der Logt JT, Heessen FW, Vink A and van Snick J ( 1988 ) Virally induced modulation of murine IgG antibody subclasses. J Exp Med 168, 2373 – 2378. | |
dc.identifier.citedreference | Coutelier J‐P, van der Logt JT, Heessen FW, Warnier G and Van Snick J ( 1987 ) IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165, 64 – 69. | |
dc.identifier.citedreference | Lenaerts L, Kelchtermans H, Geboes L, Matthys P, Verbeken E, De Clercq E and Naesens L ( 2008 ) Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection. Antimicrob Agents Chemother 52, 1462 – 1471. | |
dc.identifier.citedreference | Welton AR, Gralinski LE and Spindler KR ( 2008 ) Mouse adenovirus infection of natural killer cell‐deficient mice. Virol 373, 163 – 170. | |
dc.identifier.citedreference | Kajon AE and Spindler KR ( 2000 ) Mouse adenovirus type 1 replication in vitro is resistant to interferon. Virology 274, 213 – 219. | |
dc.identifier.citedreference | Anderson VE, Nguyen Y and Weinberg JB ( 2009 ) Effects of allergic airway disease on mouse adenovirus type 1 respiratory infection. Virology 391, 25 – 32. | |
dc.identifier.citedreference | McCarthy MK and Weinberg JB ( 2015 ) The immunoproteasome and viral infection: a complex regulator of inflammation. Front Microbiol 6, 21. | |
dc.identifier.citedreference | McCarthy MK, Malitz DH, Molloy CT, Procario MC, Greiner KE, Zhang L, Wang P, Day SM, Powell SR and Weinberg JB ( 2016 ) Interferon‐dependent immunoproteasome activity during mouse adenovirus type 1 infection. Virology 498, 57 – 68. | |
dc.identifier.citedreference | Castro‐Jorge L, Pretto CD, Smith AB, Foreman O, Carnahan KE and Spindler KR ( 2017 ) A protective role for IL‐1 signaling during mouse adenovirus type 1‐induced encephalitis. J Virol 91, e02106 – 16. | |
dc.identifier.citedreference | Sergerie Y, Rivest S and Boivin G ( 2007 ) Tumor necrosis factor‐alpha and interleukin‐1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. J Infect Dis 196, 853 – 860. | |
dc.identifier.citedreference | McCarthy MK, Zhu L, Procario MC and Weinberg JB ( 2014 ) IL‐17 contributes to neutrophil recruitment but not to control of viral replication during acute mouse adenovirus type 1 respiratory infection. Virology 456–457, 259 – 267. | |
dc.identifier.citedreference | McCarthy MK, Levine RE, Procario MC, McDonnell PJ, Zhu L, Mancuso P, Crofford LJ, Aronoff DM and Weinberg JB ( 2013 ) Prostaglandin E2 induction during mouse adenovirus type 1 respiratory infection regulates inflammatory mediator generation but does not affect viral pathogenesis. PLoS ONE 8, e77628. | |
dc.identifier.citedreference | Lehrer RI and Lu W ( 2012 ) alpha‐Defensins in human innate immunity. Immunol Rev 245, 84 – 112. | |
dc.identifier.citedreference | Smith JG, Silvestry M, Lindert S, Lu W, Nemerow GR and Stewart PL ( 2010 ) Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog 6, e1000959. | |
dc.identifier.citedreference | Smith JG and Nemerow GR ( 2008 ) Mechanism of adenovirus neutralization by human alpha‐defensins. Cell Host Microbe 3, 11 – 19. | |
dc.identifier.citedreference | Nguyen EK, Nemerow GR and Smith JG ( 2010 ) Direct evidence from single‐cell analysis that human {alpha}‐defensins block adenovirus uncoating to neutralize infection. J Virol 84, 4041 – 4049. | |
dc.identifier.citedreference | Feng GS, Chong K, Kumar A and Williams BR ( 1992 ) Identification of double‐stranded RNA‐binding domains in the interferon‐induced double‐stranded RNA‐activated p68 kinase. Proc Natl Acad Sci USA 89, 5447 – 5451. | |
dc.identifier.citedreference | McCormack SJ, Thomis DC and Samuel CE ( 1992 ) Mechanism of interferon action: Identification of a RNA binding domain within the N‐terminal region of the human RNA‐dependent P1/eIF‐2 alpha protein kinase. Virol 188, 47 – 56. | |
dc.identifier.citedreference | Patel RC and Sen GC ( 1992 ) Identification of the double‐stranded RNA‐binding domain of the human interferon‐inducible protein kinase. J Biol Chem 267, 7671 – 7676. | |
dc.identifier.citedreference | Wek RC ( 2018 ) Role of eIF2alpha kinases in translational control and adaptation to cellular stress. Cold Spring Harb Perspect Biol 10, a032870. | |
dc.identifier.citedreference | Farrell PJ, Balkow K, Hunt T, Jackson RJ and Trachsel H ( 1977 ) Phosphorylation of initiation factor elF‐2 and the control of reticulocyte protein synthesis. Cell 11, 187 – 200. | |
dc.identifier.citedreference | Dzananovic E, McKenna SA and Patel TR ( 2018 ) Viral proteins targeting host protein kinase R to evade an innate immune response: a mini review. Biotechnol Genet Eng Rev 34, 33 – 59. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.